Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110 USD | +3.58% | -.--% | -12.00% |
31/05 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
07/05 | WACKER CHEMIE AG : Gets a Neutral rating from DZ Bank | ZD |
Sales 2024 * | 613.74Cr 665.6Cr 56TCr | Sales 2025 * | 660.21Cr 716Cr 60TCr | Capitalization | 506.22Cr 548.99Cr 46TCr |
---|---|---|---|---|---|
Net income 2024 * | 22Cr 24Cr 2.04TCr | Net income 2025 * | 41Cr 45Cr 3.74TCr | EV / Sales 2024 * | 0.87 x |
Net Debt 2024 * | 25Cr 27Cr 2.27TCr | Net Debt 2025 * | 20Cr 21Cr 1.78TCr | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
12.6
x | Employees | 16,425 |
Yield 2024 * |
2.42% | Yield 2025 * |
3.99% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 day | +3.58% | ||
1 month | +5.01% | ||
3 months | +0.27% | ||
6 months | -7.33% | ||
Current year | -12.00% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 01/15/01 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 08/08/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08/08/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08/08/08 |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 110 | +3.58% | 200 |
Delayed Quote OTC Markets, May 24, 2024 at 08:44 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.05% | 1.94TCr | |
+5.08% | 419.18Cr | |
+17.49% | 158.93Cr | |
+2.84% | 131.22Cr | |
+19.82% | 96Cr | |
-11.55% | 69Cr | |
-36.36% | 57Cr | |
-13.97% | 29Cr | |
-12.92% | 25Cr |
- Stock Market
- Equities
- WCH Stock
- WKCMF Stock